Human UC-MSC exosomes intravenously transplanted into mice with MCD-induced NASH improved MCD-induced weight loss and liver damage, and down-regulated pro-inflammatory cytokines TNF-α, IL-6, and IL-1β in the plasma [158]. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatohepatitis.